Zhejiang Zhenyuan Share Co Ltd Market Cap ($303.62 Million)
Market Cap & Net Worth: Zhejiang Zhenyuan Share Co Ltd (000705)
Zhejiang Zhenyuan Share Co Ltd market cap. Zhejiang Zhenyuan Share Co Ltd (SHE:000705) has a market capitalization of $303.62 Million (CN¥2.07 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #14494 globally and #4277 in its home market, demonstrating a -4.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Zhenyuan Share Co Ltd's stock price CN¥6.21 by its total outstanding shares 334123286 (334.12 Million). Also see Zhejiang Zhenyuan Share Co Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Zhejiang Zhenyuan Share Co Ltd Market Cap History (2015–2026)
Zhejiang Zhenyuan Share Co Ltd market cap history from 2015 to 2026. Data shows change from $873.30 Million to $303.62 Million (-5.61% CAGR). Check Zhejiang Zhenyuan Share Co Ltd stock price for real-time trading data and today's change.
Zhejiang Zhenyuan Share Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Zhenyuan Share Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Zhejiang Zhenyuan Share Co Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.19x
Zhejiang Zhenyuan Share Co Ltd's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.50x
Zhejiang Zhenyuan Share Co Ltd's market cap is 19.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $609.49 Million | $2.44 Billion | $45.28 Million | 0.25x | 13.46x |
| 2017 | $384.09 Million | $2.58 Billion | $61.08 Million | 0.15x | 6.29x |
| 2018 | $283.16 Million | $2.86 Billion | $70.88 Million | 0.10x | 3.99x |
| 2019 | $312.58 Million | $3.24 Billion | $211.57 Million | 0.10x | 1.48x |
| 2020 | $343.31 Million | $3.44 Billion | $89.39 Million | 0.10x | 3.84x |
| 2021 | $424.15 Million | $3.61 Billion | $77.30 Million | 0.12x | 5.49x |
| 2022 | $381.60 Million | $4.15 Billion | $77.91 Million | 0.09x | 4.90x |
| 2023 | $527.97 Million | $4.11 Billion | $81.64 Million | 0.13x | 6.47x |
| 2024 | $386.74 Million | $3.74 Billion | $34.73 Million | 0.10x | 11.14x |
| 2025 | $442.48 Million | $2.28 Billion | $22.69 Million | 0.19x | 19.50x |
Competitor Companies of 000705 by Market Capitalization
Companies near Zhejiang Zhenyuan Share Co Ltd in the global market cap rankings as of November 5, 2026. Also see Zhejiang Zhenyuan Share Co Ltd total assets for a full breakdown of the balance sheet.
Key companies related to Zhejiang Zhenyuan Share Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #20 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #43 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1417.99 |
| #20 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #29 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $276.32 |
| #43 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $294.83 |
Market Capitalization of Zhejiang Zhenyuan Share Co Ltd (2015–2026)
Market capitalization of Zhejiang Zhenyuan Share Co Ltd from 2015 to today. Between 2015 and today, Zhejiang Zhenyuan Share Co Ltd's market cap moved from $873.30 Million to $ 303.62 Million, with a yearly change of -5.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥303.62 Million | -31.38% |
| 2025 | CN¥442.48 Million | +14.41% |
| 2024 | CN¥386.74 Million | -26.75% |
| 2023 | CN¥527.97 Million | +38.36% |
| 2022 | CN¥381.60 Million | -10.03% |
| 2021 | CN¥424.15 Million | +23.55% |
| 2020 | CN¥343.31 Million | +9.83% |
| 2019 | CN¥312.58 Million | +10.39% |
| 2018 | CN¥283.16 Million | -26.28% |
| 2017 | CN¥384.09 Million | -36.98% |
| 2016 | CN¥609.49 Million | -30.21% |
| 2015 | CN¥873.30 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Zhejiang Zhenyuan Share Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $303.62 Million USD |
| MoneyControl | $303.62 Million USD |
| MarketWatch | $303.62 Million USD |
| marketcap.company | $303.62 Million USD |
| Reuters | $303.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Zhenyuan Share Co Ltd
Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally. Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provide… Read more